Jane Street’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-269,948
| Closed | -$11M | – | 6772 |
|
|
2024
Q2 | $11M | Buy |
+269,948
| New | +$11M | ﹤0.01% | 995 |
|
|
2024
Q1 | – | Sell |
-253,424
| Closed | -$10.7M | – | 6471 |
|
|
2023
Q4 | $10.7M | Buy |
253,424
+212,098
| +513% | +$8.99M | ﹤0.01% | 883 |
|
|
2023
Q3 | $902K | Sell |
41,326
-93,864
| -69% | -$2.05M | ﹤0.01% | 3014 |
|
|
2023
Q2 | $4.3M | Buy |
135,190
+92,234
| +215% | +$2.93M | ﹤0.01% | 1638 |
|
|
2023
Q1 | $1.05M | Buy |
42,956
+33,435
| +351% | +$815K | ﹤0.01% | 2749 |
|
|
2022
Q4 | $300K | Buy |
+9,521
| New | +$300K | ﹤0.01% | 3964 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6504 |
|
|
2022
Q2 | – | Sell |
-23,434
| Closed | -$820K | – | 6458 |
|
|
2022
Q1 | $820K | Sell |
23,434
-885
| -4% | -$31K | ﹤0.01% | 3191 |
|
|
2021
Q4 | $788K | Sell |
24,319
-1,343
| -5% | -$43.5K | ﹤0.01% | 2988 |
|
|
2021
Q3 | $757K | Sell |
25,662
-30,333
| -54% | -$895K | ﹤0.01% | 2963 |
|
|
2021
Q2 | $1.44M | Buy |
+55,995
| New | +$1.44M | ﹤0.01% | 2137 |
|